Adverse effects of ropinirole-treated restless leg syndrome (RLS) during smoking cessation.

Author(s): Juergens TM

Affiliation(s): Department of Veterans Affairs, University of Wisconsin School of Medicine and Public Health, Madison, WI. 53705, USA. Timothy.Juergens@med.va.gov

Publication date & source: 2008-08-15, J Clin Sleep Med., 4(4):371-2.

Publication type: Case Reports

The impact of nicotine on drug metabolism should be carefully considered, including its impact on ropinirole. The author presents a case in which a patient with RLS effectively treated with ropinirole (Requip) experienced profound side effects from ropinirole when she stopped smoking.